Cortical Neuroplasticity by Muscle Pain of Pain-induced Plasticity

Aalborg University24 enrolled

Overview

The purpose of this study is to investigate the sensory-motor cortical excitability response to delayed onset muscle soreness (DOMS) on Extensor Carpi Radialis (ECR) muscle during muscle hyperalgesia provoked by nerve growth factor (NGF).

The purpose of this study is to assess changes in sensory-motor cortical excitability during experimental muscle hyperalgesia across several days provoked by injections of nerve growth factor (NGF) into the Extensor Carpi Radialis (ECR) muscle and delayed onset muscle soreness (DOMS) of the ECR muscle. It was hypothesized that muscle hyperalgesia across several days would result in: i) Increased sensory cortical excitability, based on somatosensory evoked potentials by means of electrical stimulation of the radial nerve, (increase of central-parietal evoked-potential P45 and decrease of frontal evoked-potential N30); ii) Increased corticomotor excitability of a ECR (increase map volume and number of active sites), assessed as motor evoked potentials induced by transcranial magnetic stimulation in primary motor cortex (M1); iii) Reduction of alpha oscillation based on nociceptive stimulus-evoked suppression of alpha activity in sensory regions (recording electrodes on contra-lateral parietal area);

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

SINGLE

Enrollment

Conditions

Nerve Growth Factor Exercise Motor Activity Abnormality of SSEPs Hyperalgesia

Interventions

Sterile solutions of recombinant human nerve growth factor (NGF)DRUG

The intramuscular injections of NGF cause muscle soreness.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy men and women * Speak and understand English. Exclusion Criteria:Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal or mental illnesses * Lack of ability to cooperate * History of chronic pain or current acute pain * Previous experience with rTMS * Contraindications to rTMS application (history of epilepsy, metal in the head or jaw etc.). * Failure to pass the "TASS questionnaire" (TASS = Transcranial Magnetic Stimulation Adult Safety Screen)

Locations (1)

Aalborg University

Aalborg, North Denmark, Denmark

Outcomes

Primary Outcomes

Pain rating

Pain on an 11-point numerical rating scale (0 = no pain, 10 = most intense pain imaginable)

Time frame: Change from baseline at 2 weeks

Secondary Outcomes

Muscle soreness

7-point Likert scale; 0 = 'a complete absence of soreness', 1 = 'a light soreness in the muscle felt only when touched/vague ache', 2 = 'a moderate soreness felt only when touched/a slight persistent ache', '3 = 'a light muscle soreness when lifting or carrying objects', 4 = 'a light muscle soreness, stiffness or weakness when moving the wrist without gripping an object', 5 = 'a moderate muscle soreness, stiffness or weakness when moving the wrist', 6 = 'a severe muscle soreness, stiffness or weakness that limits the ability to move'

Time frame: Change from baseline at 2 weeks

Patient-rated Tennis Elbow Evaluation

The Patient-rated Tennis Elbow Evaluation will be used to assess average pain and disability of the injected arm

Time frame: Change from baseline at 2 weeks

Pressure pain thresholds

Pressure applied to the surface of the skin using a handheld algometer.

Time frame: Change from baseline at 2 weeks

Motor evoked potentials

Transcranial magnetic stimualtion will be used to evoke motor evoked potentials (MEPs) to the extensor carpi radialis muscle

Time frame: Change from baseline at 1 week

Sensory evoked potentials

EEG recodring

Time frame: Change from baseline at 1 week

Alpha oscillations

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.